Trials / Conditions / Non-Active Secondary Progressive Multiple Sclerosis
Non-Active Secondary Progressive Multiple Sclerosis
3 registered clinical trials studyying Non-Active Secondary Progressive Multiple Sclerosis — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Suspended | IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis NCT06677710 | Indapta Therapeutics, INC. | Phase 1 |
| Recruiting | Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis NCT06890923 | Tiziana Life Sciences LTD | Phase 2 |
| Available | Intermediate-Size Patient Population Expanded Access: Foralumab in Non-Active Secondary Progressive MS Patient NCT06802328 | Tiziana Life Sciences LTD | — |